Prevalence Of Drug-drug Interactions In An Ethiopian Teaching Hospital | 13346
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Prevalence of drug-drug interactions in an Ethiopian teaching hospital

International Summit on Clinical Pharmacy & Dispensing

Fisseha Shiferie

Accepted Abstracts: Clinic Pharmacol Biopharmaceut

DOI: 10.4172/2167-065X.S1.004

Drug-drug interaction (DDI) refers to the interference of a drug in the action of another drug. Frequency of drug interactions varies with the number of drugs used in combination; from 3 to 5 % in patients receiving few drugs to 20% when 10 to 20 drugs are used. Computer systems have proved helpful in identifying interactions that otherwise are increasingly enormous and difficult to keep track for health professionals. The purpose of the present study was to assess the prevalence of DDIs in an Ethiopian teaching hospital from prescription papers containing two or more drugs. A retrospective study of prescription papers containing two or more drugs from September 2012 to January 2013 was carried out and the analysis of potential drug interactions was done using the online version of Micromedex /Drug-Reax system. 964 prescriptions containing more than two dugs were collected and a total of 580 potential drug interactions were found. The interaction between Ampicillin and Gentamicin, found in (29.48%) prescriptions, was the most prevalent; though with minor severity. During the study period the most prevalent drug interaction with major severity was that between Digoxin and Spironolactone (13.44%). The presence of drug interactions is a permanent risk in hospitals. The utilization of computer programs to identify potentially interacting drug combinations and the pharmacist participation in pharmacotherapy decision making are some ways of reducing this risk.